Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients.
Mantasha TabassumSoumya G ChikermaneCamille JohnsonNoor M AbdulkareemElisabeth M WangMichael L JohnsonMeghana V Trivedi
Published in: Cardio-oncology (London, England) (2024)
Our findings suggest that metoprolol is associated with a reduced risk of CV mortality in BC patients. Future studies are needed to confirm these findings and understand the mechanism of action.